Patterns of failure in patients with stage I, grade 3 carcinoma of the endometrium.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  1990-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0360-3016(90)90477-2PMID 2211200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Operative treatment in stage I endometrial carcinoma with deep myometrial invasion and/or grade 3 tumor surgically limited to the corpus uteri. No recurrence with only primary surgery

  1990cited by this paper
• Prognostic factors and sites of failure in FIGO Stage I, Grade 3 endometrial carcinoma.

  1987cited by this paper
• Primary radiation therapy for medically inoperable patients with endometrial carcinoma--stages I-II.

  1987cited by this paper
• Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study

  1987cited by this paper
• Management of high-grade stage I adenocarcinoma of the endometrium: hysterectomy following low dose external beam pelvic irradiation.

  1986cited by this paper
• Medically inoperable stage I adenocarcinoma of the endometrium treated with radiotherapy alone.

  1986cited by this paper
• Risk factors and recurrent patterns in Stage I endometrial cancer.

  1985cited by this paper
• Comparison of Clinical and Surgical Staging in Patients With Endometrial Carcinoma

  1985cited by this paper
• Stage I, grade III adenocarcinoma of the endometrium treated with surgery and irradiation. Sites of failure and correlation of failure rate with irradiation technique

  1984cited by this paper
• What can be expected when radiation therapy becomes the only curative alternative for endometrial cancer?

  1984cited by this paper
• Prognostic significance of interval from preoperative irradiation to hysterectomy for endometrial carcinoma

  1984cited by this paper
• Adenocarcinoma of the endometrium analysis of 256 cases with disease limited to the uterine corpus: Treatment comparisons

  1983cited by this paper
• Radiotherapeutic alternatives to standard management of adenocarcinoma of the endometrium.

  1983cited by this paper
• Analysis of residual disease following preoperative radiotherapy versus initial surgery in endometrial carcinoma.

  1982cited by this paper
• Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables.

  1982cited by this paper
• Stage I grade III endometrial carcinoma: evaluation of treatment and recommendations for management.

  1981cited by this paper
• PROGNOSTIC SIGNIFICANCE OF NEGATIVE HYSTERECTOMY SPECIMEN FOLLOWING INTRACAVITARY IRRADIATION IN STAGE I ENDOMETRIAL CARCINOMA

  1981cited by this paper
• Postoperative External Irradiation and Prognostic Parameters in Stage I Endometrial Carcinoma: CLINICAL AND HISTOPATHOLOGIC STUDY OF 540 PATIENTS

  1980cited by this paper
• A prospective trail comparing hysterectomy, hysterectomy plus vaginal radium, and uterine radium plus hysterectomy in stage I endometrial carcinoma.

  1979cited by this paper
• The role of radiation therapy in clinical Stage I carcinoma of the endometrium.

  1976cited by this paper
• Management of the patient with early endometrial carcinoma

  1974cited by this paper
• The value of preoperative or postoperative treatment by radium for carcinoma of the uterine body.

  1971cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Clinical outcomes with triple tandem brachytherapy for medically inoperable endometrial cancer in a high-risk patient population.

  2025cites this paper
• Malignant diseases of the uterus

  2022cites this paper
• Hybrid PET/MRI in Staging Endometrial Cancer

  2022cites this paper
• Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort

  2021cites this paper
• Analysis of tumor mutation burden combined with immune infiltrates in endometrial cancer

  2021cites this paper
• Long-Term Follow-Up Results of Adjuvant Intensity-Modulated Radiotherapy with Concurrent Paclitaxel and Cisplatin in High-Risk Endometrial Cancer Patients

  2019cites this paper
• Location of recurrences in high-risk stage Iendometrial cancer patients not given postoperative radiotherapy: A Danish gynecological cancer group study

  2019cites this paper
• A tumor board report of an 83-year-old woman with stage IB grade 3 endometrioid endometrial adenocarcinoma.

  2019cites this paper
• Evolving trends in the management of high-intermediate risk endometrial cancer in the United States.

  2019cites this paper
• Adjuvant therapy for high-risk endometrial cancer: recent evidence and future directions

  2018cites this paper
• In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

  2018cites this paper
• Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

  2018cites this paper
• Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer

  2017cites this paper
• Radiation therapy improves disease-specific survival in women with Stage II endometrioid endometrial cancer-Brachytherapy may be sufficient.

  2017cites this paper
• Concomitant chemoradiation treatment in selected Stage I endometrioid endometrial cancers.

  2016cites this paper
• Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial

  2016cites this paper
• Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial.

  2016cites this paper
• ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer

  2015cites this paper
• ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.

  2015cites this paper
• NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity‐modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer

  2015cites this paper
• ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up.

  2015cites this paper
• The Impact of Tumor Grade on Survival End Points and Patterns of Recurrence of 949 Patients With Early-Stage Endometrioid Carcinoma: A Single Institution Study

  2014cites this paper
• Chapitre 20 – Radiothérapie des cancers gynécologiques pelviens

  2013cites this paper
• Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology)

  2013cites this paper
• Risk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma

  2012cites this paper
• 32-Neoplastic Diseases of the Uterus

  2012cites this paper
• Cancer de l ’ endomètre Endometrial cancer

  2011cites this paper
• Ergebnisse der adjuvanten Strahlentherapie beim Endometriumkarzinom im Stadium Ic an der radioonkologischen Universitätsklinik Tübingen - Eine Retrospektive Studie

  2010cites this paper
• [Endometrial cancer].

  2010cites this paper
• Pharmacotherapy of endometrial cancer

  2009cites this paper
• New aspects of adjuvant therapy in endometrial cancer: current standards and future directions.

  2008cites this paper
• Acute toxicity of postoperative IMRT and chemotherapy for endometrial cancer

  2007cites this paper
• Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis.

  2007cites this paper
• Neoplastic Diseases of the Uterus

  2007cites this paper
• Chemotherapy in endometrial cancer.

  2006cites this paper
• High-risk surgical stage 1 endometrial cancer: analysis of treatment outcome

  2006cites this paper
• Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer.

  2006cites this paper
• The role of radiotherapy in the treatment of endometrial carcinoma

  2005cites this paper
• Future Developments in Radiation Therapy for Endometrial Carcinoma

  2005cites this paper
• The Role of Surgery in Advanced and Relapsed Disease

  2005cites this paper
• Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.

  2004cites this paper
• Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial.

  2004cites this paper
• Clinical Analysis of Recurrent and Advanced Staged Endometrial Cancer

  2004cites this paper
• Chapter 19 – Management of Early-Stage Endometrial Cancer

  2004cites this paper
• Systemic therapies for endometrial carcinoma

  2004cites this paper
• Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation.

  2003cites this paper
• Combined modality therapy in the treatment of gynecologic malignancies.

  2003cites this paper
• Advances in the management of endometrial adenocarcinoma. A review.

  2002cites this paper
• Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?

  2002cites this paper
• Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma.

  2002cites this paper
• Postoperative irradiation in endometrial cancer: still a matter of controversy.

  2001cites this paper
• Tailoring radiation to the extent of disease for uterine-confined endometrial cancer.

  2000cites this paper
• Surgery followed by radiotherapy in endometrial cancer: analysis of survival and patterns of failure.

  1999cites this paper
• Analysis of initial failure site and spread pattern in endometrial carcinoma: a Japanese experience.

  1999cites this paper
• Endometrial cancer.

  1997cites this paper
• Endometrial carcinoma--relative effectiveness of adjuvant irradiation vs therapy reserved for relapse.

  1996cites this paper
• [Prognostic factors in endometrial cancer: apropos of 206 cases treated at the Curie Institute].

  1995cites this paper
• Exclusive radiation therapy in endometrial carcinoma.

  1993cites this paper
• Zur Strahlentherapie des Endometriumkarzinoms

  1992cites this paper
• Zur Situation der gynäkologischen Radiologie heute — eine Einführung

  1992cites this paper
• Vaginal Recurrence After FIGO Stage I Endometrial Cancer

  year unknowncites this paper